The first gene therapies approved to treat sickle cell disease in December 2023 are struggling on the market. But there are glimpses of forward momentum as Vertex and Genetix Bio provide updates.
Sickle Cell Gene Therapies Casgevy and Lyfgenia Still Lacking Traction 2 Years In Read More »
Why Incentives Became Structural Elements in Digital Gaming Digital gaming platforms operate in a competitive environment where user attention is limited and switching costs are low. In this context, incentive systems are no longer optional additions. They have become foundational component …
The Strategic Role of Bonus Systems in Online Gaming Ecosystems Read More »
In a 6-3 decision, the court rejected President Trump’s claim that a 1977 law gave him the authority to impose broad tariffs globally.
Supreme Court invalidates Trump tariffs based on emergency powers Read More »
In a 6-3 decision, the court rejected President Trump’s claim that a 1977 law gave him the authority to impose broad tariffs globally.
Supreme Court invalidates Trump tariffs based on emergency powers Read More »
Shares in the company lost about half their value in Friday trading after the clinical trial failed to demonstrate a statistically significant reduction in stage III and IV cancers.
Grail’s multi-cancer early detection test misses study goal Read More »
Executives on an earnings call said CHS would be less “programmatic” about divestitures moving forward. The hospital operator has divested 35% of its hospital portfolio since 2019.
CHS could slow pace of divestitures as it makes progress paying debt Read More »
Across Argentina, small businesses are undergoing a quiet but meaningful transformation. Shops that once relied almost entirely on foot traffic are now combining physical presence with digital channels to stay competitive. This shift is not driven by trend chasing but by necessity, resilience, and c …
How Local Small Businesses in Argentina Are Adapting to Digital Commerce Trends Read More »
The company has integrated its Eversense 365 implant with Sequel Med Tech’s insulin delivery system to automate the management of Type 1 diabetes.
Senseonics launches automated insulin dosing system with 1-year CGM Read More »
Medtronic is investing in the rollout of the Symplicity Spyral renal denervation procedure, including hiring for new market development roles, CEO Geoff Martha said on an earnings call.
Medtronic’s blood pressure device wins coverage nod in Japan Read More »
The drugstore retailer said it was simplifying its organization to speed up decision-making in a move impacting at least 600 workers.
